The research, which analyzed the medical records of 2.5 million VA patients, suggests these medications could help with cardiovascular, kidney and liver diseases and even improve blood clotting, respiration and infection resistance.
Additionally, the study, published Jan. 20 in Nature Medicine, indicates that the drugs could reduce suicidal thoughts, challenging earlier concerns about their mental health effects.
However, the research also highlighted some potential risks, including gastrointestinal issues, reflux, headaches and pancreatitis. An unexpected link to arthritis was also observed, though researchers noted this finding warrants further investigation.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
